Non-inferiority Sample Size Estimation [Power / Sample Size]

posted by sury – India, 2019-04-16 10:44 (1688 d 10:54 ago) – Posting: # 20171
Views: 3,882

Hii All...

Anyone know about the sample size estimation for the non inferiority clinical trials, as per the literatures and some google says to consider the NI Margin to some percentage and estimate the sample size

I have tried to do the same in FARTSSIE23 (Non-inferiority, Parallel), but in addition to that Standard deviation is necessary for the same and in SAS (PROC POWER), we need to provide the CV to estimate the sample size

Can we assume the standard deviation or we need to provide the exact Standard deviation (obtained from the literatures on the drug) ?

Dose the same criteria applicable as that of the ISCV concept for the bio equivalence studies?


Best Regards...


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,811 posts in 4,783 threads, 1,640 registered users;
25 visitors (0 registered, 25 guests [including 15 identified bots]).
Forum time: 20:39 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5